Cargando…
Final Report of the First Refractory Germ Cell Tumor Treated with Sunitinib Malate
Patients with advanced germ cell tumors can be cured with cisplatin-based chemotherapy, but the outcome remains unsatisfactory for patients with relapsed disease, including those patients with refractory disease after bone marrow transplantation. Targeted therapies have changed the standard of care...
Autores principales: | Gasent Blesa, Joan Manel, Grande Pulido, Enrique, Laforga Canales, Juan, Alberola Candel, Vicente |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2914388/ https://www.ncbi.nlm.nih.gov/pubmed/20737043 http://dx.doi.org/10.1159/000260901 |
Ejemplares similares
-
PSA Decrease with Fulvestrant Acetate in a Hormone-Resistant Metastatic Prostate Cancer Patient: A Case Report
por: Gasent Blesa, Joan Manel, et al.
Publicado: (2009) -
Amelanotic Anorectal Malignant Melanoma: Case Report with Immunohistochemical Study and Literature Review
por: Laforga Canales, Juan B., et al.
Publicado: (2009) -
Durable Complete Remission of a Brainstem Glioma Treated with a Combination of Bevacizumab and Cetuximab
por: Blesa, Joan Manel Gasent, et al.
Publicado: (2012) -
Old and New Insights in the Treatment of Thyroid Carcinoma
por: Gasent Blesa, Joan Manel, et al.
Publicado: (2010) -
Graft-versus-Host Disease-Like Pattern in Mycophenolate Mofetil Related Colon Mucosal Injury: Role of FISH in Establishing the Diagnosis
por: Behling, Kathryn C., et al.
Publicado: (2009)